Advanced Flow Cytometry – Rapid Analysis for Complex Cell-based Models

White Paper May 27, 2020

Advances in our understanding of cell biology and assay technologies have resulted in the use of cell-based assays far earlier in the drug discovery workflow. This creates a significant challenge for labs; traditional cell-based approaches are not designed for the high throughput screening demands of early stage candidate identification. Labs therefore need to find new ways of working to deal with the needs of modern drug discovery pipelines.

Download this whitepaper to discover a rapid, high-throughput solution for cell-based screening assays that:

Uses minimal amounts of sample
Accelerates time-to-results
Has multiple applications

VIEW WHITE PAPER

Related White Papers

Affinity Analysis for Accelerated Screening and Characterization of Lead Molecules

White Paper

One of the common molecular analyses is the determination of a lead molecule’s binding kinetics and affinity to the target. This warrants the need for analytical instruments capable of characterizing such molecules. Download this whitepaper to discover an approach that accurately measures multiple high-affinity interactions over long run times.

AI-Powered Analytics Transforms LIMS Data Into Valuable, Action-Ready Insights

White Paper

Data accessibility has been a challenge because the lab operator’s relationship to data is usually prescribed by preset LIMS features. Using data science algorithms, it is now possible to process and integrate all LIMS and enterprise data to provide valuable insights and timely, meaningful recommendations. Access this whitepaper to discover a technology that provides a holistic view of your data, delivers statistical and business analysis and increases productivity.

Join the mRNA Vaccine Race With Affinity Purification

White Paper

mRNA based interventions are becoming much more prevalent in current times, with several leading SARS-CoV-2 vaccines relying on mRNA technology. Access this whitepaper to learn about an affinity-based method that can streamline mRNA vaccine production and be used for biotherapeutic development.

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free